Protein Aggregation and Particle Formation: Effects of Formulation, Interfaces, and Drug Product Manufacturing Operations

This chapter contains sections titled: Introduction Roles of Conformational and Colloidal Stability in Reducing Rates of Aggregation Effects of Interfaces on Protein Aggregation Critical Processing Steps during Drug Product Manufacturing of Biopharmaceuticals Particles in Parenteral Products and Visible Inspection Summary and Outlook References